Publications

Title

Author

Year

Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights.

Saula, AY; Cevik, M; CLIFF, JM; Ronacher, K; Bowness, R;

2026

Frontiers in immunology, (2026).17, 10.3389/fimmu.2026.1803046.

Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis.

Gul, M; Ali, S; Rehman, A; Qasim, M; Ali, R; PHELAN, JE; Waheed, A; Ahmad, S; Hussain, M; CAMPINO, S; CLARK, TG; Khan, TA;

2026

Pathogens, (2026).15 5 10.3390/pathogens15050455.

Diagnostic and prognostic accuracy of the Mycobacterium tuberculosis host response 3-gene cartridge among tuberculosis household contacts in Mozambique, Tanzania, and Zimbabwe: a prospective, longitudinal, diagnostic and prognostic accuracy cohort study.

LARSSON, L; Olaru, ID; Behnke, A-L; Marambire, ET; Chipinduro, M; CALDERWOOD, CJ; Banze, D; Mfinanga, A; Nhamuave, C; Mwambola, HL; Held, K; Gupta, RK; Minja, LT; Khosa, C; Heinrich, N; KRANZER, K; ERASE-TB consortium,;

2026

The Lancet Infectious Diseases, (2026).26 8 10.1016/S1473-3099(26)00114-3.

Manualised package intervention to achieve treatment adherence in people with tuberculosis: the IMPACT pilot cluster-RCT.

Lipman, M; Abubakar, I; Campbell, CN; Clarke, C; Copas, AJ; Costello, P; Darvell, M; Horne, R; Hunter, RM; Jones, AS; Karat, AS; Kielmann, K; Kılıç, A; Kunst, H; Mandelbaum, M; Moon, Z; Story, A; Weng, JY; STAGG, HR;

2026

Health technology assessment (Winchester, England), (2026).30 28 10.3310/GJML0604.

Interferon-gamma release assay positivity in populations at high risk of TB infection.

Dagnew, AF; Han, LL; Cinar, A; Gaikwad, D; Garcia-Basteiro, AL; Gler, MT; Hadinegoro, SR; Hanekom, WA; Lama, JR; Muyoyeta, M; Musala, S; Nduba, V; Rolla, VC; Roy, T; SUTHERLAND, JS; Viegas, S; WAJJA, A; Walker, TM; Noble, R; Schlehuber, L; Sunshine, J; Schmidt, AC; TBV02-E01 Study Group,;

2026

IJTLD open, (2026).3 4 10.5588/ijtldopen.25.0684.

Integrating tuberculosis control into maternal and newborn health services during pregnancy and postpartum is an urgent priority.

OKOMO, U; NKEREUWEM, E; BLENCOWE, H; BANKE-THOMAS, A; TOGUN, T;

2026

PLOS global public health, (2026).6 4 10.1371/journal.pgph.0006241.

The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysis.

Su, JS; Stover, J; Pretorius, C; Winskill, P; SWEENEY, S; Hallett, TB; Menzies, NA;

2026

PLoS medicine, (2026).23 4 10.1371/journal.pmed.1005036.

Trade-offs in diagnostic algorithm, population coverage, and duration of community screening for tuberculosis: A modelling study.

HORTON, KC; Richards, AS; SCHWALB, A; HOUBEN, RM G J;